The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-obesity Drugs Market Research Report 2024
Synopsis
Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.
The global Anti-obesity Drugs market was valued at US$ 66890 million in 2023 and is anticipated to reach US$ 87320 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
The report analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 41.45 percent over the period 2013-2022.
This report aims to provide a comprehensive presentation of the global market for Anti-obesity Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-obesity Drugs.
Report Scope
The Anti-obesity Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-obesity Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-obesity Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Segment by Type
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Segment by Application
Kids
Adults
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-obesity Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-obesity Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.
The global Anti-obesity Drugs market was valued at US$ 66890 million in 2023 and is anticipated to reach US$ 87320 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
The report analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 41.45 percent over the period 2013-2022.
This report aims to provide a comprehensive presentation of the global market for Anti-obesity Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-obesity Drugs.
Report Scope
The Anti-obesity Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-obesity Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-obesity Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Segment by Type
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Segment by Application
Kids
Adults
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-obesity Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-obesity Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti-obesity Drugs Market Overview
1.1 Product Overview and Scope of Anti-obesity Drugs
1.2 Anti-obesity Drugs Segment by Type
1.2.1 Global Anti-obesity Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Peripherally Acting Anti-obesity Drugs
1.2.3 Centrally Acting Anti-obesity Drugs
1.3 Anti-obesity Drugs Segment by Application
1.3.1 Global Anti-obesity Drugs Market Value by Application: (2024-2030)
1.3.2 Kids
1.3.3 Adults
1.4 Global Anti-obesity Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-obesity Drugs Revenue 2019-2030
1.4.2 Global Anti-obesity Drugs Sales 2019-2030
1.4.3 Global Anti-obesity Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-obesity Drugs Market Competition by Manufacturers
2.1 Global Anti-obesity Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-obesity Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-obesity Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Anti-obesity Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-obesity Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-obesity Drugs, Product Type & Application
2.7 Anti-obesity Drugs Market Competitive Situation and Trends
2.7.1 Anti-obesity Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-obesity Drugs Players Market Share by Revenue
2.7.3 Global Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-obesity Drugs Retrospective Market Scenario by Region
3.1 Global Anti-obesity Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-obesity Drugs Global Anti-obesity Drugs Sales by Region: 2019-2030
3.2.1 Global Anti-obesity Drugs Sales by Region: 2019-2024
3.2.2 Global Anti-obesity Drugs Sales by Region: 2025-2030
3.3 Global Anti-obesity Drugs Global Anti-obesity Drugs Revenue by Region: 2019-2030
3.3.1 Global Anti-obesity Drugs Revenue by Region: 2019-2024
3.3.2 Global Anti-obesity Drugs Revenue by Region: 2025-2030
3.4 North America Anti-obesity Drugs Market Facts & Figures by Country
3.4.1 North America Anti-obesity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-obesity Drugs Sales by Country (2019-2030)
3.4.3 North America Anti-obesity Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-obesity Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-obesity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-obesity Drugs Sales by Country (2019-2030)
3.5.3 Europe Anti-obesity Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-obesity Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-obesity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-obesity Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-obesity Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-obesity Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-obesity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-obesity Drugs Sales by Country (2019-2030)
3.7.3 Latin America Anti-obesity Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-obesity Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-obesity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-obesity Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-obesity Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-obesity Drugs Sales by Type (2019-2030)
4.1.1 Global Anti-obesity Drugs Sales by Type (2019-2024)
4.1.2 Global Anti-obesity Drugs Sales by Type (2025-2030)
4.1.3 Global Anti-obesity Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anti-obesity Drugs Revenue by Type (2019-2030)
4.2.1 Global Anti-obesity Drugs Revenue by Type (2019-2024)
4.2.2 Global Anti-obesity Drugs Revenue by Type (2025-2030)
4.2.3 Global Anti-obesity Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anti-obesity Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-obesity Drugs Sales by Application (2019-2030)
5.1.1 Global Anti-obesity Drugs Sales by Application (2019-2024)
5.1.2 Global Anti-obesity Drugs Sales by Application (2025-2030)
5.1.3 Global Anti-obesity Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anti-obesity Drugs Revenue by Application (2019-2030)
5.2.1 Global Anti-obesity Drugs Revenue by Application (2019-2024)
5.2.2 Global Anti-obesity Drugs Revenue by Application (2025-2030)
5.2.3 Global Anti-obesity Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anti-obesity Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Anti-obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Anti-obesity Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Corporation Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Anti-obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novo Nordisk Anti-obesity Drugs Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Anti-obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Anti-obesity Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Arena Pharmaceuticals
6.4.1 Arena Pharmaceuticals Corporation Information
6.4.2 Arena Pharmaceuticals Description and Business Overview
6.4.3 Arena Pharmaceuticals Anti-obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Arena Pharmaceuticals Anti-obesity Drugs Product Portfolio
6.4.5 Arena Pharmaceuticals Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Anti-obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Roche Anti-obesity Drugs Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Anti-obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GlaxoSmithKline Anti-obesity Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Orexigen Therapeutics
6.6.1 Orexigen Therapeutics Corporation Information
6.6.2 Orexigen Therapeutics Description and Business Overview
6.6.3 Orexigen Therapeutics Anti-obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Orexigen Therapeutics Anti-obesity Drugs Product Portfolio
6.7.5 Orexigen Therapeutics Recent Developments/Updates
6.8 Vivus
6.8.1 Vivus Corporation Information
6.8.2 Vivus Description and Business Overview
6.8.3 Vivus Anti-obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vivus Anti-obesity Drugs Product Portfolio
6.8.5 Vivus Recent Developments/Updates
6.9 Amylin
6.9.1 Amylin Corporation Information
6.9.2 Amylin Description and Business Overview
6.9.3 Amylin Anti-obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Amylin Anti-obesity Drugs Product Portfolio
6.9.5 Amylin Recent Developments/Updates
6.10 Alizyme
6.10.1 Alizyme Corporation Information
6.10.2 Alizyme Description and Business Overview
6.10.3 Alizyme Anti-obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Alizyme Anti-obesity Drugs Product Portfolio
6.10.5 Alizyme Recent Developments/Updates
6.11 Boehringer Ingelheim
6.11.1 Boehringer Ingelheim Corporation Information
6.11.2 Boehringer Ingelheim Anti-obesity Drugs Description and Business Overview
6.11.3 Boehringer Ingelheim Anti-obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Boehringer Ingelheim Anti-obesity Drugs Product Portfolio
6.11.5 Boehringer Ingelheim Recent Developments/Updates
6.12 Eisai
6.12.1 Eisai Corporation Information
6.12.2 Eisai Anti-obesity Drugs Description and Business Overview
6.12.3 Eisai Anti-obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Eisai Anti-obesity Drugs Product Portfolio
6.12.5 Eisai Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-obesity Drugs Industry Chain Analysis
7.2 Anti-obesity Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-obesity Drugs Production Mode & Process
7.4 Anti-obesity Drugs Sales and Marketing
7.4.1 Anti-obesity Drugs Sales Channels
7.4.2 Anti-obesity Drugs Distributors
7.5 Anti-obesity Drugs Customers
8 Anti-obesity Drugs Market Dynamics
8.1 Anti-obesity Drugs Industry Trends
8.2 Anti-obesity Drugs Market Drivers
8.3 Anti-obesity Drugs Market Challenges
8.4 Anti-obesity Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
